BIOMAT Database Logo BIOMAT Database Logo

Treatment of deep venous thrombosis with low molecular weight heparins. 1998

F Ruiz, and D Berman

UI MeSH Term Description Entries
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006495 Heparin, Low-Molecular-Weight Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. LMWH,Low-Molecular-Weight Heparin,Low Molecular Weight Heparin,Heparin, Low Molecular Weight
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides

Related Publications

F Ruiz, and D Berman
Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis.
March 1995, Archives of internal medicine,
F Ruiz, and D Berman
Deep venous thrombosis: low-molecular-weight heparins in perioperative prophylaxis.
January 1995, Cleveland Clinic journal of medicine,
F Ruiz, and D Berman
Cost-effectiveness of low-molecular-weight heparins for deep venous thrombosis.
March 2000, Annals of internal medicine,
F Ruiz, and D Berman
Low-molecular-weight heparins for treatment of deep vein thrombosis.
September 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
F Ruiz, and D Berman
Treatment of deep vein thrombosis using low-molecular-weight heparins.
November 2001, The American journal of managed care,
F Ruiz, and D Berman
[Low molecular weight heparins. No increase of the cost of treatment of deep venous thrombosis].
January 1994, Presse medicale (Paris, France : 1983),
F Ruiz, and D Berman
[The future of low molecular weight heparins in the curative treatment of deep venous thrombosis].
March 1994, L'union medicale du Canada,
F Ruiz, and D Berman
Treatment of deep vein thrombosis (DVT) with low molecular weight heparins (LMWH).
January 1992, Advances in experimental medicine and biology,
F Ruiz, and D Berman
[Treatment of deep vein thrombosis with low molecular weight heparins at home].
March 2003, Anales de medicina interna (Madrid, Spain : 1984),
F Ruiz, and D Berman
Prevention of recurrences after deep venous thrombosis: role of low-molecular-weight heparins.
January 1997, Seminars in thrombosis and hemostasis,
Copied contents to your clipboard!